North America Eye Health Supplements Market By Formulation, By Indication, By Ingredient Type, By Country, Industry Analysis and Forecast, 2020 - 2026

The North America Eye Health Supplements Market is expected to witness market growth of 9.3% CAGR during the forecast period (2020-2026).

An increasing prevalence of AMD across the world is further contributing to segment growth. According to the International Agency for the Prevention of Blindness (IAPB), AMD is the third most leading cause of blindness globally and it is also reported as the principal cause of blindness in the developed countries comprising significant aging populations. In addition to it, according to BrightFocus Foundation, about 11 million U.S. individuals are expected to have some or the other form of AMD in 2019, which is likely to double by 2050 end. The number of individuals suffering from macular degeneration is expected to reach approximately 196.0 million by 2020, worldwide, which is further expected to increase over the forthcoming years.

Additionally, the advanced eye health supplements have been launched in order to fulfil the unmet demand from unaddressed individuals who are suffering from vision impairment across the globe is likely to bring robust growth in the market. For example, in October 2019, Bausch + Lomb launched its eye health supplement namely PreserVision AREDS 2 Formula minigel eye vitamins. Since the PreserVision AREDS 2 Formula minigel is easy to swallow and became an alternative for the company’s PreserVision AREDS 2 Formula soft gels used for advanced AMD.

Furthermore, the existence of a strong distribution network and sales channel for these supplements is also contributing to the market growth. A study by NutraIngredients stated that due to the COVID-19 outbreak, sales of eye health supplements from the online platforms have increased significantly in the past few months.

Based on Formulation, the market is segmented into Tablets, Capsules, Powder, Softgels, and Liquid. Based on Indication, the market is segmented into Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Inflammation, Cataract and Others. Based on Ingredient Type, the market is segmented into Lutein and Zeaxanthin, Antioxidants, Flavonoids, Alpha-Lipoic Acid, Omega-3 Fatty acids, Coenzyme Q10, Astaxanthin and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include The Nature’s Bounty Co. (The Carlyle Group L.P.), Pfizer, Inc., Alticor Inc. (Amway Corporation), Novartis AG, Kemin Industries, Inc., ZeaVision LLC (EyePromise), EyeScience Labs, LLC, Vitabiotics Ltd., Nutrivein and NutraChamps, Inc.

Scope of the Study

Market Segments covered in the Report:

By Formulation

• Tablets
• Capsules
• Powder
• Softgels,
• Liquid

By Indication

• Age-related Macular Degeneration (AMD)
• Dry Eye Syndrome
• Inflammation
• Cataract
• Others

By Ingredient Type

• Lutein and Zeaxanthin
• Antioxidants
• Flavonoids
• Alpha-Lipoic Acid
• Omega-3 Fatty acids
• Coenzyme Q10
• Astaxanthin
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Companies Profiled

• The Nature’s Bounty Co. (The Carlyle Group L.P.)
• Pfizer, Inc.
• Alticor Inc. (Amway Corporation)
• Novartis AG
• Kemin Industries, Inc.
• ZeaVision LLC (EyePromise)
• EyeScience Labs, LLC
• Vitabiotics Ltd.
• Nutrivein
• NutraChamps, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free